AP2.DEAP2.DEXETRA
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank33
3Y CAGR-40.6%
5Y CAGR-30.9%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-40.6%/yr
Quarterly compound
5Y CAGR
-30.9%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q1 2026 | 1.30% |
| Q4 2025 | 1.78% |
| Q3 2025 | 0.90% |
| Q2 2025 | 3.96% |
| Q1 2025 | 0.12% |
| Q4 2024 | 2.63% |
| Q3 2024 | 6.50% |
| Q2 2024 | 4.11% |
| Q1 2024 | -4.44% |
| Q4 2023 | 2.87% |
| Q3 2023 | -1.03% |
| Q2 2023 | 0.52% |
| Q1 2023 | 6.20% |
| Q4 2022 | 2.98% |
| Q3 2022 | 2.77% |
| Q2 2022 | 4.89% |
| Q1 2022 | 5.14% |
| Q4 2021 | -2.81% |
| Q3 2021 | 3.73% |
| Q2 2021 | 1.82% |
| Q1 2021 | 8.21% |
| Q4 2020 | -2.10% |
| Q3 2020 | 4.00% |
| Q2 2020 | -0.36% |
| Q1 2020 | 7.18% |
| Q4 2019 | 0.00% |
| Q3 2019 | 1.38% |
| Q2 2019 | -1.55% |
| Q1 2019 | -0.39% |
| Q4 2018 | 2.78% |
| Q3 2018 | -0.98% |
| Q2 2018 | 4.30% |
| Q1 2018 | 4.72% |
| Q4 2017 | 2.64% |
| Q3 2017 | 3.89% |
| Q2 2017 | 4.80% |
| Q1 2017 | 5.84% |
| Q4 2016 | 2.07% |
| Q3 2016 | 0.00% |
| Q2 2016 | 3.21% |